Anxiety & Depression · Hayward, CA
Treatment-resistant depression usually means depression has not improved enough after at least two antidepressant trials.[1] Treatment-resistant anxiety is less standardized, but a 2024 World Psychiatry consensus paper describes it as anxiety that remains impairing after appropriate evidence-based treatment has been tried.[2] When both are happening together, the problem is not just “more symptoms.” It becomes a loop.
Depression says, “What’s the point?” Anxiety says, “Something bad will happen if you try.” That combination can make a person’s life painfully small. One condition drains the energy to move; the other makes movement feel dangerous. Over time, the person may stop trusting their own ability to act.
Why this can feel so stuck
Anxiety and depression both have physiological foundations. Sleep, stress hormones, inflammation, neurotransmitters, genetics, medical conditions, substances, and medication response can all matter. But they also become learned patterns in the neuroplastic brain.
Depression can teach the brain that effort is pointless. Anxiety can teach the brain that discomfort means danger.[4] A person avoids one responsibility, then feels more hopeless because it is still there. Fear creates avoidance, and avoidance gives depression more evidence. This is why treatment-resistant does not mean hopeless. It means the plan needs to treat both sides of the loop.
Anxious depression remits less often — and takes longer to respond.
The treatment has to come from more than one angle
A more complete plan usually needs several support beams. First, cover the physiology. For severe depression, medication may be necessary. Some people may need medication changes, augmentation, sleep treatment, or evaluation for medical contributors. When depression is treatment-resistant, options like TMS, ECT, or SPRAVATO/esketamine may also come up depending on the person.[1][5]
Second, treat the learning problem. For anxiety, therapy is often central. Exposure-based therapy helps the brain face triggers safely instead of organizing life around avoidance.[4] CBT, trauma-focused therapy, behavioral activation, or guided self-therapy can also help retrain the habits of thought that keep fear and hopelessness alive.
Third, rebuild the daily structure. Sleep rhythm, food, movement, reduced substance use, social contact, and regular responsibilities matter because they shape the nervous system every day. A chaotic life rhythm can feed both anxiety and depression. A steadier rhythm gives the brain fewer reasons to stay on alert.
What a combined plan usually includes.
- Cover the physiology — medication, augmentation, sleep treatment, and evaluation for medical contributors.
- Treat the learning problem — exposure-based therapy so the brain faces triggers safely instead of organizing life around avoidance.
- Add CBT, trauma-focused work, or behavioral activation to retrain the habits of thought that keep fear and hopelessness alive.
- Address sleep and trauma directly — they shape the nervous system every day and feed both conditions when ignored.
- Rebuild daily structure — steady sleep, food, movement, reduced substance use, and social contact.
- Consider neurostimulation or esketamine (TMS, ECT, SPRAVATO) when depression is adequate-but-unresponsive after appropriate trials.
The takeaway
Treatment-resistant anxiety and depression can feel like a locked room, but the lock often has more than one part. Medication may help the body. Therapy may retrain the fear pattern. Behavioral activation may rebuild action before motivation returns. Lifestyle structure may stabilize the nervous system enough for the rest of treatment to work.
The goal is not to find one magic button. The goal is to stop letting fear and hopelessness design your life. When treatment targets both the physiology and the learned patterns, the plan becomes more precise — and the loop becomes easier to interrupt. This matters especially because anxious depression tends to remit less often and take longer to respond than depression without prominent anxiety,[3] which is exactly why a single-angle plan so often stalls.
Stop letting fear and hopelessness design your life.
The goal is not one magic button — it’s a plan that treats the body, the fear pattern, and the daily rhythm together. We’ll look at where the loop is stuck and build the plan around you.
References
- McIntyre RS, Alsuwaidan M, Baune BT, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22(3):394-412. PMID: 37713549 · doi:10.1002/wps.21120.
- Domschke K, Seuling PD, Schiele MA, et al. The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline. World Psychiatry. 2024;23(1):113-123. PMID: 38214637 · doi:10.1002/wps.21177.
- Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342-351. PMID: 18172020 · doi:10.1176/appi.ajp.2007.06111868.
- Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10-23. PMID: 24864005 · doi:10.1016/j.brat.2014.04.006.
- U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray — Highlights of Prescribing Information. Revised 2025. accessdata.fda.gov (211243s019lbl.pdf). (J&J standalone monotherapy approval for treatment-resistant depression announced January 21, 2025.)

Comments are closed